The TRPM8 channels have attracted increasing attention in the past decade as promising drug targets for treatment of different pathologic processes, such as colonic inflammation [4,11,12,21], dry eye disease (DED) [26], tumors [34], oropharyngeal dysphagia [13], chronic cough [14], and hypertension [15]. This evidence concerns the gene TRPM8 and Dysphagia.